Categories AlphaGraphs, Earnings, Health Care

Biogen tops market estimates in Q3, lowers guidance

Biogen (NASDAQ: BIIB) reported third-quarter 2020 financial results before the opening bell on Wednesday. The biotechnology giant reported a 6% decline in Q3 revenues to $3.38 billion, beating the Wall Street consensus. Earnings of $8.84 per share were also stronger than what analysts had anticipated.

BIIB shares were trading flat immediately following the announcement. The stock has slipped 9% since the beginning of this year.

Biogen Q3 2020 earnings.

Looking forward to listening to management/ analyst comments on Q4 results? Stay tuned here for Biogen Q3 2020 earnings call transcript

Biogen also lowered its guidance for the full year, hurt by multiple Tecfidera generic entrants in the US.

Prior performance

Most Popular

Key highlights from Autodesk (ADSK) Q4 2021 earnings results

Autodesk, Inc. (NASDAQ: ADSK) today reported its fourth quarter financial results for the period ended January 31, 2021. Net income for the fourth quarter was $911.3 million, or $4.10 per

Infographic: Beyond Meat (BYND) reports wider Q4 loss; Revenue up 4%

Beyond Meat (NASDAQ: BYND), a specialist in plant-based meat substitutes, Thursday reported a wider loss for the fourth quarter, despite an increase in revenues. The numbers also missed the consensus

Virgin Galactic stock tanks on delayed test flight

Virgin Galactic (NYSE: SPCE) reported fourth-quarter 2020 financial results after the regular market hours on Thursday. The space tourism company reported zero revenue in the fourth quarter, compared to $529,000

Add Comment
Viewing Highlight